BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 1703918)

  • 1. The Lewis X antigen. A new paraffin section marker for Reed-Sternberg cells.
    Ree HJ; Teplitz C; Khan A
    Cancer; 1991 Mar; 67(5):1338-46. PubMed ID: 1703918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraffin section markers for Reed-Sternberg cells. A comparative study of peanut agglutinin, Leu-M1, LN-2, and Ber-H2.
    Ree HJ; Neiman RS; Martin AW; Dallenbach F; Stein H
    Cancer; 1989 May; 63(10):2030-6. PubMed ID: 2564804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of combining antigranulocyte with antileukocyte antibodies in differentiating Hodgkin's disease from non-Hodgkin's lymphoma.
    Medeiros LJ; Weiss LM; Warnke RA; Dorfman RF
    Cancer; 1988 Dec; 62(12):2475-81. PubMed ID: 2973368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bauhinia purpurea--a new paraffin section marker for Reed-Sternberg cells of Hodgkin's disease. A comparison with Leu-M1 (CD15), LN2 (CD74), peanut agglutinin, and Ber-H2 (CD30).
    Sarker AB; Akagi T; Jeon HJ; Miyake K; Murakami I; Yoshino T; Takahashi K; Nose S
    Am J Pathol; 1992 Jul; 141(1):19-23. PubMed ID: 1352944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leu M1 and S100 in Hodgkin's disease and non-Hodgkin's lymphomas.
    Kornstein MJ; Bonner H; Gee B; Cohen R; Brooks JJ
    Am J Clin Pathol; 1986 Apr; 85(4):433-7. PubMed ID: 3754087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of sialylated Leu-M1 antigen in histiocytosis X.
    Santamaria M; Llamas L; Ree HJ; Sheibani K; Ho YS; Su IJ; Hsu SM
    Am J Clin Pathol; 1988 Feb; 89(2):211-6. PubMed ID: 3257635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues.
    Pinkus GS; Thomas P; Said JW
    Am J Pathol; 1985 May; 119(2):244-52. PubMed ID: 3887932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte and HLA-D region specific monoclonal antibodies in the diagnosis of Hodgkin's disease.
    Norton AJ; Isaacson PG
    J Clin Pathol; 1985 Nov; 38(11):1241-6. PubMed ID: 3864794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peanut agglutinin. A useful marker for histiocytosis X and interdigitating reticulum cells.
    Ree HJ; Kadin ME
    Cancer; 1986 Jan; 57(2):282-7. PubMed ID: 2417675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies in the diagnosis of Hodgkin's disease. The search for a rational panel.
    Chittal SM; Caverivière P; Schwarting R; Gerdes J; Al Saati T; Rigal-Huguet F; Stein H; Delsol G
    Am J Surg Pathol; 1988 Jan; 12(1):9-21. PubMed ID: 2827535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological and immunohistochemical investigation of non-Hodgkin's lymphoma combined with Hodgkin's disease.
    Hansmann ML; Fellbaum C; Hui PK; Lennert K
    Histopathology; 1989 Jul; 15(1):35-48. PubMed ID: 2548946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies reactive in routinely processed tissue sections of malignant lymphoma, with emphasis on T-cell lymphomas.
    Strickler JG; Weiss LM; Copenhaver CM; Bindl J; McDaid R; Buck D; Warnke R
    Hum Pathol; 1987 Aug; 18(8):808-14. PubMed ID: 3301626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical characterization of two new monoclonal antibodies (LN-4, LN-5) reactive with human macrophage subsets and derived malignancies in B5-fixed, paraffin-embedded tissues.
    Bhoopat L; Turner RR; Stathopoulos E; Meyer PR; Taylor CR; Marder RJ; Epstein AL
    Blood; 1988 Apr; 71(4):1079-85. PubMed ID: 3281719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leucocyte common antigen in the differential diagnosis of Hodgkin's disease.
    Strauchen JA
    Hematol Oncol; 1989; 7(2):149-53. PubMed ID: 2563987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An autopsy case of malignant histiocytosis with Reed-Sternberg-like cells.
    Nakanuma Y; Kurumaya H; Kurashima K
    Acta Pathol Jpn; 1989 Jan; 39(1):79-83. PubMed ID: 2540613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced staining for Leu M1 (CD15) in Hodgkin's disease using a secondary antibody specific for immunoglobulin M.
    LeBrun DP; Kamel OW; Dorfman RF; Warnke RA
    Am J Clin Pathol; 1992 Jan; 97(1):135-8. PubMed ID: 1345892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-BLA.36 monoclonal antibody shows reactivity with Hodgkin's cells and B lymphocytes in frozen and paraffin-embedded tissues.
    Della Croce DR; Imam A; Brynes RK; Nathwani BN; Taylor CR
    Hematol Oncol; 1991; 9(2):103-14. PubMed ID: 1869241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
    Gonzalez CL; Medeiros LJ; Jaffe ES
    Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody Leu-22 (L60) permits the demonstration of some neoplastic T cells in routinely fixed and paraffin-embedded tissue sections.
    Wieczorek R; Buck D; Bindl J; Knowles DM
    Hum Pathol; 1988 Dec; 19(12):1434-43. PubMed ID: 2973429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leu-22: a preferential marker for T-lymphocytes in paraffin sections. Staining profile in T- and B-cell lymphomas, Hodgkin's disease, other lymphoproliferative disorders, myeloproliferative diseases, and various neoplastic processes.
    Said JW; Stoll PN; Shintaku P; Bindl JM; Butmarc JR; Pinkus GS
    Am J Clin Pathol; 1989 May; 91(5):542-9. PubMed ID: 2785753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.